Reaction Details Report a problem with these data
Target
Cannabinoid receptor 2
Ligand
BDBM419271
Substrate
n/a
Meas. Tech.
Radioligand Binding Assay
Ki
58.0±n/a nM
Citation
 Gobbi, L; Grether, U; Guba, W; Kretz, J; Martin, RE; Westphal, MV [1,2,3]triazolo[4,5-d]pyrimidine derivatives US Patent  US10457684 Publication Date 10/29/2019 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM419271
Synonyms:
(3S)-1-[5-[Difluoro(phenyl)methyl]-3-[[2-ethynyl-6-[3-(trifluoromethyl)diazirin-3-yl]phenyl]methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol | US10457684, Example 15
Type:
Small organic molecule
Emp. Form.:
C26H19F5N8O
Mol. Mass.:
554.4741
SMILES:
O[C@H]1CCN(C1)c1nc(nc2n(Cc3c(cccc3C3(N=N3)C(F)(F)F)C#C)nnc12)C(F)(F)c1ccccc1 |r,c:22|
Structure:
Search PDB for entries with ligand similarity: